Alicia Trejo

Title: The Innovative Contributions of Alicia Trejo

Introduction

Alicia Trejo is a notable inventor based in Mexico City, MX. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of simvastatin, a widely used cholesterol-lowering medication. His innovative methods have garnered attention in the scientific community.

Latest Patents

Alicia Trejo holds a patent for a method titled "Method for alkylating the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin." This patent describes a process for producing simvastatin from lovastatin in high yield and pharmaceutical purity. The method involves forming an amide of lovastatin and protecting the free hydroxyl groups with hexamethyldisilazane (HMDS). This innovative approach allows for the methylation of the alpha-carbon of the protected lovastatin amide, leading to the formation of simvastatin. The process is designed to avoid the production of acid, simplifying the reaction and enhancing the overall efficiency.

Career Highlights

Alicia Trejo has made a mark in the pharmaceutical industry through his work at Fermic S.A. de C.V. His expertise in organic chemistry and innovative methodologies has positioned him as a valuable asset in the development of pharmaceutical compounds. His patent reflects his commitment to advancing drug synthesis techniques.

Collaborations

Alicia has collaborated with notable colleagues, including Edvige Galeazzi and Gustavo A. Garcia. These partnerships have contributed to the successful development and refinement of his patented methods.

Conclusion

Alicia Trejo's contributions to the field of pharmaceuticals through his innovative patent demonstrate his expertise and commitment to advancing medical science. His work continues to impact the industry positively, paving the way for future advancements in drug synthesis.